| Targeted cancer therapy through antibody fragments-decorated nanomedicines A Alibakhshi, FA Kahaki, S Ahangarzadeh, H Yaghoobi, F Yarian, ... Journal of Controlled Release 268, 323-334, 2017 | 155 | 2017 |
| Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody F Kazemi-Lomedasht, M Behdani, KP Bagheri, M Habibi-Anbouhi, ... Molecular immunology 65 (1), 58-67, 2015 | 80 | 2015 |
| Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer M Evazalipour, M D'Huyvetter, BS Tehrani, M Abolhassani, K Omidfar, ... Contrast Media & Molecular Imaging 9 (3), 211-220, 2014 | 69 | 2014 |
| Nanobodies as novel agents for targeting angiogenesis in solid cancers R Arezumand, A Alibakhshi, J Ranjbari, A Ramazani, S Muyldermans Frontiers in immunology 8, 292547, 2017 | 65 | 2017 |
| Web-based tools for miRNA studies analysis F Shaker, A Nikravesh, R Arezumand, SH Aghaee-Bakhtiari Computers in biology and medicine 127, 104060, 2020 | 37 | 2020 |
| Identification and characterization of a novel nanobody against human placental growth factor to modulate angiogenesis R Arezumand, R Mahdian, S Zeinali, G Hassanzadeh-Ghassabeh, ... Molecular immunology 78, 183-192, 2016 | 26 | 2016 |
| An update on antiviral antibody-based biopharmaceuticals S Ahangarzadeh, Z Payandeh, R Arezumand, K Shahzamani, F Yarian, ... International immunopharmacology 86, 106760, 2020 | 24 | 2020 |
| Antibody‐drug therapeutic conjugates: Potential of antibody‐siRNAs in cancer therapy F Yarian, A Alibakhshi, S Eyvazi, R Arezumand, S Ahangarzadeh Journal of Cellular Physiology 234 (10), 16724-16738, 2019 | 19 | 2019 |
| Synthesis, characterization and in vivo evaluation of cadmium telluride quantum dots toxicity in mice by toxicometabolomics approach M Khoshkam, Y Baghdadchi, R Arezumand, A Ramazani Toxicology Mechanisms and Methods 28 (7), 539-546, 2018 | 14 | 2018 |
| Effects of curcuma Longa extract on telomerase activity in lung and breast cancer cells J Ranjbari, A Alibakhsh, R Arezumand, M Pourhassan-Moghaddam, ... Zahedan Journal of Research in Medical Sciences 16 (10), 2014 | 13 | 2014 |
| Recombinant expression and purification of human placental growth factor 1 and specific camel heavy chain polyclonal antibody preparation R Arezumand, R Mahdian, M Behdani, H Khanahmad, J Langari, ... Saudi Journal of Biological Sciences 21 (1), 35-39, 2014 | 13 | 2014 |
| Development of a recombinant monospecific anti-PLGF bivalent nanobody and evaluation of it in angiogenesis modulation A Nikooharf, R Arezumand, K Mansouri, AH Khoshi, ... Molecular biotechnology 62, 580-588, 2020 | 11 | 2020 |
| Rational affinity enhancement of fragmented antibody by ligand-based affinity improvement approach Z Ebrahimi, S Asgari, RA Cohan, R Hosseinzadeh, G Hosseinzadeh, ... Biochemical and biophysical research communications 506 (3), 653-659, 2018 | 11 | 2018 |
| Reducing effect of insulin resistance on alpha-synuclein gene expression in skeletal muscle A Khoshi, G Goodarzi, R Mohammadi, R Arezumand, M Moghbeli, ... Diabetology & metabolic syndrome 11, 1-5, 2019 | 9 | 2019 |
| Recombinant expression and purification of functional vascular endothelial growth factor-121 in the baculovirus expression system N Mohseni, A Jahanian-Najafabadi, F Kazemi-Lomedasht, R Arezomand, ... Asian Pacific Journal of Tropical Medicine 9 (12), 1195-1199, 2016 | 9 | 2016 |
| Design and expression of fusion protein consists of HBsAg and polyepitope of HCV as an HCV potential vaccine M Gholizadeh, H Khanahmad, A Memarnejadian, MR Aghasadeghi, ... Advanced biomedical research 4 (1), 243, 2015 | 6 | 2015 |
| In vitro evaluation of Vegf-Pseudomonas exotoxin: A conjugated on tumor cells J Langari, M Karimipoor, M Golkar, H Khanahmad, S Zeinali, S Omidinia, ... Advanced biomedical research 6 (1), 144, 2017 | 5 | 2017 |
| Nanobody as a New Generation of Functional Proteins: Nanobody as a new functional domains Z Ebrahimi, R Arezumand, A Ramazani Iranian Journal of Pharmaceutical Sciences 14 (3), 91-106, 2018 | 3 | 2018 |
| Associations between serum levels of C3, C4, and total classical complement activity in COVID-19 patients at the time of admission and clinical outcome A Razi, A Azimian, R Arezumand, A Solati, HN Ahmadabad Инфекция и иммунитет 12 (5), 869-874, 2022 | 2 | 2022 |
| Generating the engineered form of a nanobody against placenta growth factor with high antiangiogenesis potential SA Hosseini, K Mansouri, S Ahmadpour, M Evazalipour, E Sharifian, ... Monoclonal antibodies in immunodiagnosis and immunotherapy 40 (1), 11-16, 2021 | 2 | 2021 |
